Serotonin Syndrome With the Concomitant Use of Triptans and SSRIs/Serotonergic Medications: Is It Time to Revisit FDA Warning?

IF 2.9 3区医学 Q2 PHARMACOLOGY & PHARMACY

Journal of Clinical Psychopharmacology Pub Date : 2024-03-01 Epub Date: 2024-01-15 DOI:10.1097/JCP.0000000000001812

Zeeshan Mansuri, Mahwish Adnan, Bhumika Shah, Chintan Trivedi, Ramu Vadukapuram, Shweta Patel, Garima Yadav, Sushma Srinivas, Maliha Ansari, Ramkrishna Makani, Raman Baweja, Abhishek Reddy

引用次数: 0

查看原文本刊更多论文

同时使用 Triptans 和 SSRIs/羟色胺能药物的羟色胺综合征：是时候重新审视 FDA 的警告了吗？

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of Clinical Psychopharmacology 医学-精神病学

CiteScore

4.00

自引率

3.40%

发文量

231

审稿时长

4-8 weeks

期刊介绍： Journal of Clinical Psychopharmacology, a leading publication in psychopharmacology, offers a wide range of articles reporting on clinical trials and studies, side effects, drug interactions, overdose management, pharmacogenetics, pharmacokinetics, and psychiatric effects of non-psychiatric drugs. The journal keeps clinician-scientists and trainees up-to-date on the latest clinical developments in psychopharmacologic agents, presenting the extensive coverage needed to keep up with every development in this fast-growing field.